Astragaloside IV- loaded heart-mitochondria dual-targeted nanomicelles improved heart injury after acute myocardial infarction

Journal Title: Biomedical Transformation - Year 2022, Vol 3, Issue 3

Abstract

Acute myocardial infarction(AMI) is a serious threat to human health due to its high morbidity and mortality. Persistent myocardial injury remains after AMI, although the mortality of AMI has been greatly reduced by drugs, interventional therapy and surgery. Astragaloside IV(AST) is one of the main active components of Astragali Radix. However, the hydrophobicity of AST limits its bioavailability. In this experiment, we developed a platelet membrane-modified poly(d, L-lactic-Co-Glycolic Acid) -block(PLGA-b) -poly(Ethylene Glycol) (PEG)-Triphenylphosphonium(TPP) (PLGA-b-PEG-TPP) polymer nanomicelles for encapsulating AST to achieve the dual targeting effect of ' heart-mitochondria ' from the ' organ-organelle ' level. In this study, the drugloaded nanomicelles were characterized by transmission electron microscope, dynamic light scattering, drug release and stability investigation. The cardiac targeting effect of drug loaded nanomicelles was confirmed by in vivo imaging. The effects of drug-loaded nanomicelles on cardiac function and myocardial injury after I/R were investigated by echocardiography, histology and serum enzymology. The effects of drug-loaded nanomicelles on cardiac mitochondrial function and inflammation were evaluated by examining mitochondrial morphology, membrane potential, reactive oxygen species(ROS)and levels of inflammatory factors in serum and heart. Compared with the free AST, the results showed that drug-loaded nanomicelles significantly improved cardiac function, myocardial injury, mitochondrial damage and cardiac inflammation after I/R . It was suggested that the drug loaded nanomicelles significantly improved the bioavailability and cardioprotective activity of AST. This experiment provides a new strategy for the delivery of hydrophobic active monomer of traditional Chinese medicine.

Authors and Affiliations

Yang Ke, Li Lan, Fan Guanwei

Keywords

Related Articles

Current status and challenges of lung transplantation in China

Lung transplantation (LTx) is the only effective treatment for patients with end-stage lung disease. The field of LTx has undergone tremendous progress over the past four decades in China. The domestic filed of LTx is in...

Overview of the development of smart healthcare in China

With the continuous development of information technology, people's lifestyle and the quality of life have further improved, people's demand for medical and health is also increasing, "smart healthcare" happens to meet p...

Research progress on the control of mosquito-borne infectious diseases by skin microbial volatiles

A variety of microorganisms inhabit the human skin, including bacteria, fungi, and viruses. Skin microbiota plays an important role in maintaining host skin homeostasis and the skin barrier function. Volatiles produced b...

Research progress and prospects of informatics of traditional Chinese medicine

With the rapid development of science and technology, biomedicine has entered a new era of big data. Massive biomedical data has speeded up the rise of medical informatics, systems biology, computational biology and the...

Research progress on transgenerational toxicity induced by emerging pollutants and underlying mechanisms in Caenorhabditis elegans

Environmental pollution is closely associated with adverse effects on human health. In recent years, growing attention has been directed toward the environmental distribution and potential toxicity of emerging pollutants...

Download PDF file
  • EP ID EP766845
  • DOI 10.12287/j.issn.2096-8965.20220307
  • Views 11
  • Downloads 0

How To Cite

Yang Ke, Li Lan, Fan Guanwei (2022). Astragaloside IV- loaded heart-mitochondria dual-targeted nanomicelles improved heart injury after acute myocardial infarction. Biomedical Transformation, 3(3), -. https://www.europub.co.uk/articles/-A-766845